Seeing Is Believing
Currently out of the existing stock ratings of Steve Scala, 47 are a BUY (74.6%), 16 are a HOLD (25.4%).
Analyst Steve Scala, currently employed at TD COWEN, carries an average stock price target met ratio of 76.59% that have a potential upside of 32.95% achieved within 765 days. Previously, Steve Scala worked at COWEN.
Steve Scala’s has documented 145 price targets and ratings displayed on 13 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ABBV, AbbVie at 07-Oct-2024.
Analyst best performing recommendations are on LLY (ELI LILLY AND COMPANY).
The best stock recommendation documented was for LLY (ELI LILLY AND COMPANY) at 4/24/2018. The price target of $95 was fulfilled within 114 days with a profit of $22.62 (31.25%) receiving and performance score of 2.74.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$226
$22.45 (11.03%)
$195
8 days ago
(31-Oct-2024)
8/9 (88.89%)
$22.13 (10.85%)
293
Buy
$231
$27.45 (13.49%)
$218
8 days ago
(31-Oct-2024)
12/14 (85.71%)
$27.13 (13.31%)
488
Buy
$215
$11.45 (5.63%)
$170
14 days ago
(25-Oct-2024)
9/10 (90%)
$27.15 (14.45%)
484
Buy
$212
$8.45 (4.15%)
$200
1 months 1 days ago
(07-Oct-2024)
14/15 (93.33%)
$17.88 (9.21%)
175
Buy
$225
$21.45 (10.54%)
$180
1 months 1 days ago
(07-Oct-2024)
14/15 (93.33%)
$30.88 (15.91%)
715
Which stock is Steve Scala is most bullish on?
Which stock is Steve Scala is most reserved on?
What Year was the first public recommendation made by Steve Scala?